Theriva Biologics, Inc. Financing Receivable, after Allowance for Credit Loss
Theriva Biologics, Inc. (TOVX) had Financing Receivable, after Allowance for Credit Loss of $700.00 thousand as of 2013-06-30, per its 10-Q filed 2013-08-14.
Discontinued › Balance Sheet › Assets
us-gaap:NotesReceivableNet · last filed 2013-08-14
- 2013-06-30: Financing Receivable, after Allowance for Credit Loss $700.00K.
- 2013-03-31: Financing Receivable, after Allowance for Credit Loss $700.00K.
- 2012-12-31: Financing Receivable, after Allowance for Credit Loss $0.00.
| Period end | Financing Receivable, after Allowance for Credit Loss |
|---|---|
| 2013-06-30 | $700.00K 10-Q · filed 2013-08-14 |
| 2013-03-31 | $700.00K 10-Q · filed 2013-05-15 |
| 2012-12-31 | $0.00 10-Q · filed 2013-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |